Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 4Breast Neoplasms 3Ovarian Neoplasms 2Lung Neoplasms 2Fatigue 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Lymphoma 1Genital Neoplasms, Female 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Disease Progression 1Colonic Neoplasms 1Cognitive Dysfunction 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Bone Neoplasms 1Adolescent and Young Adult Cancer Patient 1

Interventions

Memantine 2acetaminophen, aspirin, caffeine drug combination 1Transcranial Direct Current Stimulation 1Time 1Sugars 1Sirolimus 1Riluzole 1Referral and Consultation 1Ramipril 1Radiotherapy, Intensity-Modulated 1Palliative Care 1Ibuprofen 1Exercise 1Donepezil 1Cognitive Behavioral Therapy 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Cognitive Dysfunction × Palliative Care × Clear all
NCT04669301 2025-07-15

Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II

University of Rochester

Phase NA Completed
72 enrolled 15 charts

Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡